Literature DB >> 34263956

Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study.

Yusuf A Rajabally1,2, Stojan Peric3, Ivo Bozovic3, Lay K Loo1, Aida Kalac4, Aleksa Palibrk3, Ivana Basta3.   

Abstract

INTRODUCTION/AIMS: Chronic inflammatory demyelinating polyneuropathy (CIDP) may be rarely preceded by infection. A causative link remains unproven, in contrast to Guillain-Barré syndrome (GBS), which is commonly postinfectious with well-demonstrated pathophysiological mechanisms of molecular mimicry following Campylobacter jejuni enteritis. Uncommonly, infections are reported before the onset of CIDP. In this study we aimed to determine the frequency and characteristics of CIDP occurring after antecedent infections or vaccinations in two large European cohorts.
METHODS: We reviewed the records of 268 subjects with "definite" or "probable" CIDP from the Inflammatory Neuropathy Clinic, Birmingham, UK (129 subjects), and from the Serbian national CIDP database (139 subjects).
RESULTS: Twenty-five of 268 (9.3%) subjects had a respiratory or gastrointestinal infection in the 6 weeks preceding CIDP onset, and 3 of 268 (1.1%) had received an influenza vaccination. CIDP disease onset occurred at a younger age (mean [standard deviation], 44.25 [17.36] years vs 54.05 [15.19] years; P < .005) and acute-onset CIDP was more common (42.9% vs 12.1%; odds ratio, 5.46; 95% confidence interval, 2.35-12.68; P < .001) in subjects with preceding infections or vaccinations. No differences in CIDP subtype, rates of cerebrospinal fluid protein level elevation, disability, or likelihood of treatment response, were observed. DISCUSSION: Antecedent infections or vaccinations may precede about 10% of cases of CIDP and are more common in younger subjects. Acute-onset CIDP is more frequent after antecedent events. These findings may suggest specific pathophysiological mechanisms in such cases.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  acute onset; chronic inflammatory demyelinating polyneuropathy; gastrointestinal; infection; respiratory; vaccination

Mesh:

Year:  2021        PMID: 34263956     DOI: 10.1002/mus.27374

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course.

Authors:  Aaron de Souza; Wai M Oo; Pradeep Giri
Journal:  J Neurol Sci       Date:  2022-03-16       Impact factor: 4.553

2.  Neuromuscular complications after COVID-19 vaccination: a series of eight patients.

Authors:  Wouter Leemans; Sofie Antonis; Wouter De Vooght; Robin Lemmens; Philip Van Damme
Journal:  Acta Neurol Belg       Date:  2022-05-02       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.